Nonpharmacological therapies for interstitial lung disease.

ABSTRACT:

A purpose of review

Interstitial lung diseases (ILDs) cause unpredictable degrees of fibrosis and inflammation in the lungs leading to functional decline and varying symptom burden for patients. Some patients may live for years and be responsive to therapy and others disease trajectory may be shorter and similar to patients with lung cancer. This ultimately affects the patient's quality of life as well as their caregiver(s).

B recent findings

Nonpharmacological therapies play an important role in treatment of interstitial lung disease. These include symptom management, pulmonary rehabilitation, oxygen therapy, and palliative care. While ILDs are associated with high morbidity and mortality, different models of care exist globally. New tools help clinicians identify and addre

SUBMITTER: Lindell KO 

PROVIDER: S-EPMC6516779 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature